Please login to the form below

Not currently logged in
Email:
Password:

Eurocom Healthcare Comms expands to Turkey

Ixir Healthcare Communications joins alliance

Ixir Healthcare Communications logo

Turkey-based Ixir Healthcare Communications has joined the Eurocom Healthcare Communications Network. 

The network was established in 2006 and is an international alliance of independent healthcare communications agencies across Europe and in the US that have reputations for creativity, competency and services to healthcare in their own countries.

Ixir Healthcare Communications, under the leadership of founder Dr Talay Toksoz, will aim to provide creative solutions to the healthcare industry across Europe and the world.

Tony Chant, president of Eurocom Healthcare Communications, commented: “We are delighted to welcome Ixir Healthcare Communications to the Network.  Dr Toksoz and his team have more than 20 years' experience providing marketing services to the Turkish healthcare industry. Along with our European and American Network partners, we are looking forward to working collaboratively with them, and extending the reach of the Network to East Europe.

“The combined skills, experience and knowledge base of our Network members, as well as the increased reach and connection with target audiences worldwide, provide first-class opportunities to healthcare brands and consumers for maximising promotional success.”

Ixir's skill base and experience has been proven in ophthalmology, targeted therapies, immunology and medical devices, in addition to self-medications such as food supplements.

Article by
Kirstie Pickering

6th March 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics